GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,964,767 | +361.6% | 583,379 | +453.6% | 0.09% | +400.0% |
| Q2 2023 | $6,274,563 | -0.9% | 105,384 | -5.7% | 0.02% | -5.3% |
| Q1 2023 | $6,330,823 | -30.1% | 111,773 | -8.4% | 0.02% | -34.5% |
| Q4 2022 | $9,061,163 | +19.7% | 122,003 | -4.0% | 0.03% | +20.8% |
| Q3 2022 | $7,571,000 | -2.1% | 127,098 | -7.7% | 0.02% | +20.0% |
| Q2 2022 | $7,732,000 | +4.8% | 137,721 | +37.7% | 0.02% | +33.3% |
| Q1 2022 | $7,380,000 | +966.5% | 100,028 | +944.2% | 0.02% | +1400.0% |
| Q4 2021 | $692,000 | -6.7% | 9,579 | -1.1% | 0.00% | -50.0% |
| Q3 2021 | $742,000 | +3.8% | 9,684 | +5.0% | 0.00% | +100.0% |
| Q2 2021 | $715,000 | +21.2% | 9,226 | -3.6% | 0.00% | 0.0% |
| Q1 2021 | $590,000 | -6.8% | 9,569 | -1.4% | 0.00% | 0.0% |
| Q4 2020 | $633,000 | +28.7% | 9,700 | -2.3% | 0.00% | 0.0% |
| Q3 2020 | $492,000 | +5.8% | 9,930 | +1.8% | 0.00% | 0.0% |
| Q2 2020 | $465,000 | – | 9,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |